AVIENCE BIOMEDICALS LTD vs CIPLA LTD

A side-by-side comparison of AVIENCE BIOMEDICALS LTD (AVIENCE) and CIPLA LTD (CIPLA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

AVIENCE BIOMEDICALS LTD and CIPLA LTD are evenly matched on the numbers (66, 2 tied). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

15.65
P/E ratio
29.54
1.82
P/B ratio
3.42
0.00%
Dividend yield
0.90%
₹14.24
EPS
₹48.02

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

25.30%
Return on equity
11.60%
21.10%
Return on capital
15.00%
24.69%
EBITDA margin
21.00%
13.72%
Net margin
13.71%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y)
7.37%
Profit CAGR (3Y)
10.88%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹155 Cr
Market cap
₹1.15L Cr
₹42 Cr
Revenue
₹28,163 Cr
₹6 Cr
Net profit
₹3,862 Cr
1.29
Debt / equity
0.02
AVIENCE BIOMEDICALS LTD
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 34.8%"]
  • ["Company might be capitalizing the interest cost", "Company has high debtors of 150 days."]
CIPLA LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
  • ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.34%"]
AVIENCE BIOMEDICALS LTD full analysis CIPLA LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

AVIENCE BIOMEDICALS LTD vs CIPLA LTD: Share Price, Valuation & Which to Buy | DocStoX